Chouairi, F., Fudim, M., Savarese, G., Szabo, B., Dahlström, U., Hage, C., … Lund, L. H. (2025). Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry. Eur J Heart Fail, 27(6), 972–978. https://doi.org/10.1002/ejhf.3578

Chouairi, Fouad, Marat Fudim, Gianluigi Savarese, Barna Szabo, Ulf Dahlström, Camilla Hage, Federica Guidetti, Lina Benson, and Lars H. Lund. “Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry.” Eur J Heart Fail 27, no. 6 (June 2025): 972–78. https://doi.org/10.1002/ejhf.3578.

Chouairi F, Fudim M, Savarese G, Szabo B, Dahlström U, Hage C, et al. Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry. Eur J Heart Fail. 2025 Jun;27(6):972–8.

Chouairi, Fouad, et al. “Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry.” Eur J Heart Fail, vol. 27, no. 6, June 2025, pp. 972–78. Pubmed, doi:10.1002/ejhf.3578.

Chouairi F, Fudim M, Savarese G, Szabo B, Dahlström U, Hage C, Guidetti F, Benson L, Lund LH. Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry. Eur J Heart Fail. 2025 Jun;27(6):972–978.